Načítá se...
The rationale for Janus kinase inhibitors for the treatment of spondyloarthritis
The pathogenesis of SpA is multifactorial and involves a range of immune cell types and cytokines, many of which utilize Janus kinase (JAK) pathways for signaling. In this review, we summarize the animal and pre-clinical data that have demonstrated the effects of JAK blockade on the underlying molec...
Uloženo v:
| Vydáno v: | Rheumatology (Oxford) |
|---|---|
| Hlavní autoři: | , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6343466/ https://ncbi.nlm.nih.gov/pubmed/29618084 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/key070 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|